Posterior reversible encephalopathy syndrome associated with Guillain-Barré syndrome: Case report and clinical management considerations.
Blood-Brain Barrier
/ diagnostic imaging
Brain
/ diagnostic imaging
Brain Edema
/ complications
Endothelium, Vascular
/ immunology
Fatal Outcome
Female
Guillain-Barre Syndrome
/ complications
Humans
Immunoglobulins, Intravenous
/ immunology
Magnetic Resonance Imaging
/ methods
Middle Aged
Plasma Exchange
/ methods
Posterior Leukoencephalopathy Syndrome
/ complications
Guillain-Barré syndrome
dysautonomia
intravenous immunoglobulins
plasma exchange
posterior reversible encephalopathy syndrome
Journal
Journal of clinical apheresis
ISSN: 1098-1101
Titre abrégé: J Clin Apher
Pays: United States
ID NLM: 8216305
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
03
09
2019
revised:
03
03
2020
accepted:
27
03
2020
pubmed:
15
4
2020
medline:
9
7
2021
entrez:
15
4
2020
Statut:
ppublish
Résumé
Around half of the patients with Guillain-Barré syndrome (GBS) present autonomic dysfunction requiring admission to intensive care unit in up to a quarter of patients. Treatment of GBS consists of plasma exchange (PE) and intravenous immunoglobulins (IVIG). Posterior reversible encephalopathy syndrome (PRES) consists in a reversible subcortical vasogenic brain edema caused by endothelial damage triggered by abrupt blood pressure changes. We report on a woman who presented with PRES in the course of GBS treated first with IVIG, and then with PE. The present report underlines the challenge that the clinicians face when these two rare syndromes concur. The literature is not helpful considering that both blood pressure fluctuations and IVIG are reported to be involved in the pathogenesis of PRES. In the present letter, both pathogenic mechanisms and clinical management considerations are discussed.
Substances chimiques
Immunoglobulins, Intravenous
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-233Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914-925.
Chen A, Kim J, Henderson G, Berkowitz A. Posterior reversible encephalopathy syndrome in Guillain-Barré syndrome. J Clin Neurosci. 2015;22(5):914-916.
Stetefeld HR, Lehmann HC, Fink GR, Burghaus L. Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller-Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome. J Stroke Cerebrovasc Dis. 2014;23(9):e423-e425.
Tombak A, Uçar MA, Akdeniz A, et al. Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases. Indian J Hematol Blood Transfus. 2017;33(1):97-105.
Chakraborty T, Kramer CL, Wijdicks EFM, Rabinstein AA. Dysautonomia in Guillain-Barré syndrome: prevalence, clinical spectrum, and outcomes. Neurocrit Care. 2019;32:113-120. https://doi.org/10.1007/s12028-019-00781-w.
Squair JW, Phillips AA, Harmon M, Krassioukov AV. Emergency management of autonomic dysreflexia with neurologic complications. CMAJ. 2016;188(15):1100-1103.
Chen PR, Chen SP. Posterior reversible encephalopathy as the first manifestation of Bickerstaff's brainstem encephalitis. BMC Neurol. 2016;16(1):215.
Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: an update. Clin Auton Res. 2019;29(3):289-299.
Colls BM. Guillain-Barré syndrome and hyponatraemia. Intern Med J. 2003;33(1-2):5-9.
Consortium for Spinal Cord Medicine. Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities. J Spinal Cord Med. 2002;25(Suppl 1):S67-S88.
Hilz MJ, Liu M, Roy S, Wang R. Autonomic dysfunction in the neurological intensive care unit. Clin Auton Res. 2019;29(3):301-311.
Aridon P, Ragonese P, Mazzola MA, et al. Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura. Neurol Sci. 2011;32(3):469-472.